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President E L Harris FRCP Meeting 9 December 1976 Role and Value of Drug Information Centres Mr N W Blacow (Regional Pharmaceutical Officer, North Western Regional Health Authority, Gateway House, Piccadilly South, Manchester M60 7LP) Drug Information Centres: a Hospital Pharmacist's View For longer than I care to admit, I have been interested in providing information on drugs and drug actions and also in developing the services to supply it. The present need for information is often attributed to the vast increase in our knowledge of these subjects in the last decade or so, but anyone who has practised in earlier times knows that medical and pharmaceutical practitioners have always had a need for unbiased information on drugs. It was to meet just such a need that William Martindale produced the first edition of his 'Extra Pharmacopoeia' in 1883. Martindale wrote in his preface:
'Sixteen years have elapsed since the publication of the last British Pharmacopeia, and during this time a number of new drugs have been introduced, many official ones have been put to new uses, and a number of nonofficial preparations of both have of necessity been employed in pharmacy. Operative surgery has been revolutionised by the Antiseptic Treatment of Wounds, Dermatology by the use of Petroleum Ointments, and Therapeutics by the introduction of such important drugs and definite chemical remedies as Salicylic Acid and Salicin, Chloral Hydrate and Croton-Chloral Hydrate, Chrysophanic Acid and Eserine, Gelsemium and Gelsemine, Homatropine and Hyoscyamine, Jaborandi and Pilocarpine, Nitrite of Amyl and Nitroglycerine, Oleated Preparations and Hypodermic Injections. To shortly describe these and their uses is the purpose of this little book.' If only we could now revolutionize medicine so easily! No doubt these advances as described at the time were considered radical, and the need for information on them was great enough to persuade Martindale to publish his book. I consider it to be highly significant that Martindale, a pharmacist, asked a medical man to join him in his work so that the 'Extra Pharmacopceia' would meet the needs of clinicians and pharmacists. I repeat, this was in 1883. The point is that we have long had a need for information on drugs; it is just that the need has become greater as the amount of information has increased and the drugs more potent.
In hospitals, pharmacists traditionally supplied information to their medical colleagues. That they have been successful is evident from the fact that the service has been continued decade after decade. It would be interesting to know why they became traditional suppliers of information, but I should guess that the tradition arose because the pharmacist had the books and the manufacturers' literature arranged in an orderly manner to meet his own information needs. Thus he could readily make them available to his medical colleagues and, I would hope, add something from his own knowledge and experience as well. The pharmacist by his education brings to bear on a drug problem a very different aspect from that of the physician. It is a complementary aspect, and one which, I would judge, is highly regarded by physicians. It is worthy of note too that the pharmaceutical industry looked to the hospital pharmacist as the distributor of information and some of those gentlemen representatives who visited hospitals a few decades ago would feel that they had done what was expected of them when they had informed the pharmacist of their firm's new drug with all the eloquence, politeness and knowledge which they commanded.
The situation now is very different. We live in a world of quickly advancing technology and most of us find it difficult enough to keep abreast of advances in our own field, let alone master other fields as well. I am confident that today's hospital pharmacists can provide answers to many of the questions put to them on drugs and their properties, but it would be unreasonable to expect them to have the time to deal with the obscure problems of others whilst keeping abreast of their own subjects.
The answer, or so we think, is to set up drug information services with staff who have both technical knowledge and experience in the information sciences. In my regional health authority, we provided the service at the regional level because we considered that requests for much factual data could adequately be provided at the hospital level and consequently the new service would probably deal with more difficult problems. Some regions have established the service at the area or district levels. It is a good thing to have these different structures, as time will show the advantages of each.
No one expects the staff in the information service to know all the answers, but they should be expected to know where to go for the correct answer. Similarly, no one expects them to have the experience to interpret all data and, in my region, each medical specialty has nominated two of its members to contribute to the work of the service by acting as advisers or by directly undertaking to answer enquiries. Dentists, pharmacists, pharmacologists, statisticians and many others also act in this way and contribute in the subjects in which they have special knowledge or expertise. Pharmacists are particularly pleased to see the appointment of clinical pharmacologists to our hospitals; they are confident that the two disciplines will work closely together to achieve the better use of drugs, which is our common objective.
If the standard for the information service is to be set at a sufficiently high level, then the contribution of this panel is of the greatest possible value. Information includes the interpretation of data, and geographical and professional boundaries should be no barrier to achieving the best interpretation possible. Thus I would see the staff of the information service interpreting data on topics within their knowledge and experience; but in other instances I would see them as collators, assembling data for forwarding to the advisers and then collating the advisers' comments and presenting them in a form suitable for the enquirer.
There is a skill in comprehending a request for information and in seeking and collating information for an answer; and these skills improve with practice. With the opportunities to develop their skills, those providing the information services would be expected to present information in response to an enquiry to a much better standard than most practitioners, medical or pharmaceutical, could accomplish for themselves even if they had the time. This I see as one of the advantages of having specialists for this work. In time I hope we shall see training courses for these specialists.
The information service in my region was established on what could be described as economic grounds: to ensure that practitionersdental, medical, nursing or pharmaceutical -make the best use of drug treatments available to them. We hope that the service will assist prescribers to choose the most suitable treatment for each patient and that it will assist pharmacists to ensure that each product is as effective and safe as our knowledge permits. I would stress that the decision whether to be influenced by the information supplied must always be left to the professional practitioner, but the service can provide unbiased information on which decisions can be based.
The Regional Drug Information Pharmacists Group defined the purpose of the drug information service as being 'to promote the safe, effective and economic use of drugs in patients by the active and passive provision of drug information to all members of the health care professions'. These objectives introduce a very important topic: the active dissemination of information.
Unfortunately, those who are the most in need of information are the least likely to be aware of their need. Wade & Hood (1972) found only a slow change in prescribing by general medical practitioners so that treatments associated with serious adverse effects continued to be prescribed. Baird et al. (1976) reported on the microbial contamination of a range of medicinal products made by hospital pharmacists. These are examples of how even conscientious health care staff may overlook some aspect of their work which could have serious consequences for patients. An active approach must be made to ensure that advances in the practice of our professions are implemented.
The pharmaceutical industry has had great experience and success in educating members of the health care professions. Most pharmaceutical firms have extensive information services containing much data on their own products and, I believe, also on those of their competitors. Information on the former they give to enquirers most generously. A few firms have offered regional drug information services direct access to their computerized data stores. It has often been asked why the industry cannot provide the entire information services to the health care professions. They have the data and they have much of the expertise to interpret the data. However, they also have a strong interest, not necessarily financial, in their own products and this diminishes their impartiality. The same risk is latent in hospital physicians or pharmacists who have worked with a drug, and I am sure that the information pharmacists are well aware of this point.
What role is there for the pharmaceutical industry in the provision of information on drugs? I see them as providers of factual data and of references to published papers on their products. Most firms scan the world's literature, using either their own staff or a commercial information service, and store the references in their well-run data bases. If they made these available to the drug information services, they would be making a valuable contribution to the work of the health care professions and perhaps be saving public expenditure on the provision of duplicate services.
It is my contention that: (1) There is a need by the health care professions for unbiased information on drugs.
(2) Whilst much information can continue to be provided locally, some enquiries will require the sophisticated services which can only be provided by those skilled in data collection or its interpretation.
(3) If advances in our knowledge are to be cofnmunicated to those who can implement them for the benefit of our patients, then there should be active dissemination of information. I am sure that drug information services, as I have briefly described them, are the best means to meet these needs. Both pharmacists and clinical pharmacologists have been providing their medical, dental, nursing and pharmaceutical colleagues with information about drugs for many years. Initially this was given on an informal basis, but the increasing complexity of modern drug therapy has led to demands for a more organized service.
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In the Northern Region we have established a clinical drug information service aimed at pro-viding medical colleagues with advice on all aspects of clinical pharmacology, pharmacokinetics, toxicology and therapeutics. Since May 1975 this service has been offered on a twenty-four-hour basis, with a duty pharmacologist available at any time of day or night. We will use our accumulated experience over the first year (Davies et al. 1976) to answer three fundamental questions: (1) Is there a need for drug information units within the National Health Service? (2) What are the logistics of their operation? (3) Is a clinical component desirable or necessary?
In the first twelve months of its operation, the Northern Region Clinical Drug Information Service (CDIS) was contacted on 404 occasions by telephone and 47 by post. Of these enquiries 87.6 % came from within the region. Although we had anticipated that the CDIS would be used exclusively by doctors, 12.2 % of enquiries were from paramedical colleagues (pharmacists and nurses), and 2.4 % from public services (mainly the police and the fire service). There is little doubt, therefore, that there is a demand for the type of service we have provided.
No less than 40 % of our enquiries were received between 5.00 p.m. and 9.00 a.m., and for this reason we regard twenty-four-hour availability as essential. Three-quarters of the enquiries we have received can be answered by experienced clinical pharmacologists either from memory, or by reference to basic texts or information sheets prepared locally. The remainder require extensive bibliographic searches, and since this is time consuming and complicated, assistance from information scientists is essential. Such personnel could be either librarians with wide knowledge of medical and pharmacological terminology, or pharmacists with training in librarianship.
Few of our enquirers were seeking purely factual information. Most (78.4 %) needed clinical pharmacological advice on the management of a specific case which usually involved discussing the possible benefits and hazards of one or more courses of action, taking into account the patient's present and past medical history. Such enquiries can be satisfactorily handled only by individuals with a medical qualification, clinical training and special expertise in pharmacology. Indeed, our experience suggests that doctors working full time in the information services, by removing themselves from active participation in clinical medicine, would inevitably diminish their capacity to advise their colleagues. At present our service has insufficient pharmaceutical expertise; this inevitably limits its scope, and we are currently reconstructing it so that both pharmacy and clinical pharmacology are adequately represented. In conclusion, therefore, our experience indicates that although drug information units are
